Craniosacral osteopathy is effective in the treatment of migraine

Craniosacral osteopathy is effective in the treatment of migraine

Share this article:

Migraine is a complex disease whose pathogenesis is not yet precisely known. One theory on the cause of the debilitating headache disorder assumes that there is a disorder in the brain in which both nerve impulses and chemical substances play a role.

Recent research from 2013 investigated the effectiveness of craniosacral therapy on migraine symptoms. In this study, four weeks of therapy with a total of six craniosacral treatments resulted in a significant reduction in migraine symptoms, providing evidence for the effectiveness of craniosacral therapy for the first time (Arnadottir et Sigurdardottir 2013).


Who is interested in the exact dates:

A cross-over study design was used and twenty patients aged between 20 and 50 years, with at least two migraine attacks per month, were randomised into two equal groups. Both groups received six craniosacral treatments within four weeks. To measure the impact of headaches on daily life, the Headache Impact Test (HIT-6) was used, which was answered weekly by the participants. 



There was a significant reduction in HIT-6 levels compared to levels before treatment started. The improvement in symptoms occurred immediately after treatment and after the last treatment and decreased over the course of the study. 



These results suggest that craniosacral treatment is effective in treating migraine. The authors suggest further research with larger sample sizes to further support the findings with evidence.



Arnadottir TS, Sigurdardottir AK. Is craniosacral therapy effective for migraine? Tested with HIT-6 Questionnaire. Complement Ther Clin Pract. 2013;19(1):11-14

Callager RM, Cutrer FM. Migraine: diagnosis, management, and new treatment options. Am J Manag Care. 2002;8(3; SUPP):S58-S73

Green C, Martin CW, Bassett K, et al. A systematic review of craniosacral therapy: biological plausibility, assessment reliability and clinical effectiveness. Complement Ther Med. 1999;7(4):201-207

Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349

Sheftell FD. American Headache Society Committee for Headache Education: ACHE. Headache Care, Res Educ Worldw Front Headache Res Ser Vol 17.. 2010;17:171

Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11(4):289-299